Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Development of a saliva-optimized RT-LAMP assay for SARS-CoV-2

Albert Dayuan Yu, Kristina Galatsis, Jian Zheng, Jasmine Quynh Le, Dingbang Ma, Stanley Perlman, Michael Rosbash
doi: https://doi.org/10.1101/2020.12.26.20248880
Albert Dayuan Yu
1Howard Hughes Medical Institute and Department of Biology, Brandeis University, Waltham, MA 02454, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristina Galatsis
1Howard Hughes Medical Institute and Department of Biology, Brandeis University, Waltham, MA 02454, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian Zheng
2Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jasmine Quynh Le
1Howard Hughes Medical Institute and Department of Biology, Brandeis University, Waltham, MA 02454, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dingbang Ma
1Howard Hughes Medical Institute and Department of Biology, Brandeis University, Waltham, MA 02454, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stanley Perlman
2Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Rosbash
1Howard Hughes Medical Institute and Department of Biology, Brandeis University, Waltham, MA 02454, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rosbash@brandeis.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Conventional reverse transcription quantitative polymerase chain reaction (RT-qPCR) technology has struggled to fulfill the unprecedented need for diagnostic testing created by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Complexity and cost hinder access to testing, and long turnaround-time decreases its utility. To ameliorate these issues, we focus on saliva and introduce several advances to colorimetric reverse-transcription loop-mediated isothermal amplification (RT-LAMP) technology; RT-LAMP offers a minimal equipment alternative to RT-qPCR. First, we validated the use of the novel dye LAMPShade Violet (LSV), which improves the visual clarity and contrast of the colorimetric readout. Second, we compared different inactivation conditions on infectivity and RNA yield from saliva. Third, we developed a ten-minute RNA purification protocol from saliva. We call this magnetic bead protocol SalivaBeads. Finally, we developed a magnetic stick, StickLAMP, which provides reliable bead-based RNA purification as well as simple and low-cost access to scalable testing from saliva.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work is supported by the Howard Hughes Medical Institute.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB Protocol #20132R Rosbash: SARS-CoV-2 Testing Initiative The Brandeis IRB, operating under Federalwide Assurance #FWA00004408, has approved the above-referenced human subjects protocol by expedited review in accordance with 45 CFR 46.110 under category (3).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data is reported in the manuscript. Raw data is available upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted January 02, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Development of a saliva-optimized RT-LAMP assay for SARS-CoV-2
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Development of a saliva-optimized RT-LAMP assay for SARS-CoV-2
Albert Dayuan Yu, Kristina Galatsis, Jian Zheng, Jasmine Quynh Le, Dingbang Ma, Stanley Perlman, Michael Rosbash
medRxiv 2020.12.26.20248880; doi: https://doi.org/10.1101/2020.12.26.20248880
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Development of a saliva-optimized RT-LAMP assay for SARS-CoV-2
Albert Dayuan Yu, Kristina Galatsis, Jian Zheng, Jasmine Quynh Le, Dingbang Ma, Stanley Perlman, Michael Rosbash
medRxiv 2020.12.26.20248880; doi: https://doi.org/10.1101/2020.12.26.20248880

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (416)
  • Anesthesia (91)
  • Cardiovascular Medicine (860)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (250)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
  • Epidemiology (8562)
  • Forensic Medicine (4)
  • Gastroenterology (384)
  • Genetic and Genomic Medicine (1753)
  • Geriatric Medicine (167)
  • Health Economics (373)
  • Health Informatics (1244)
  • Health Policy (621)
  • Health Systems and Quality Improvement (468)
  • Hematology (196)
  • HIV/AIDS (374)
  • Infectious Diseases (except HIV/AIDS) (10303)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (212)
  • Neurology (1678)
  • Nursing (97)
  • Nutrition (251)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (451)
  • Oncology (929)
  • Ophthalmology (263)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (114)
  • Palliative Medicine (40)
  • Pathology (253)
  • Pediatrics (536)
  • Pharmacology and Therapeutics (253)
  • Primary Care Research (208)
  • Psychiatry and Clinical Psychology (1770)
  • Public and Global Health (3841)
  • Radiology and Imaging (624)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (168)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)